First Uses of Veniti Vici Venous Stent System Reported



 

January 24, 2014
Veniti Vici Venous Stent System Venous Therapies Clinical Study CE Mark
January 24, 2014 — Patients in the European Union (EU) received the first Veniti Vici Venous Stent System implants to treat symptomatic venous outflow obstruction of the lower extremities.
 
Stephen Black, a consultant vascular surgeon at St. George's Vascular Institute, St. George's Hospital, London, implanted Veniti Vici Stents in five patients on Jan. 14-15, 2014. 
 
"The Veniti Vici Venous Stent appears to have the radial strength and vein coverage to provide optimal results in patients with symptomatic outflow obstruction of the lower extremities," Black said. 


 
The stent features including end-to-end crush resistance, radial resistive force, flexibility and continuous vein coverage. The Veniti Vici Venous Stent System has received CE marking and is seeking approval from the U.S. Food and Drug Administration (FDA) to begin clinical studies of the device in the United States. 
 
A live case demonstration at the Leipzig Interventional Course (LINC) is schedule for Jan. 28, 2014 in Leipzig, Germany.
 
The Veniti Veni RF Plus Endovascular Ablation System has also received CE marking. The Veniti
Vidi IVC Filter System is in early stages of clinical studies in New Zealand, and Veniti is seeking approval from the FDA to begin clinical studies of the device in the United States. 
 
For more information: www.veniti.com